[VRAX] QoQ Quarter Result on 30-Sep-2022 [#Q2]

Stock
[VRAX] Virax Biolabs Group Limited
Announcement Date
29-Sep-2022
Financial Year
2023
Quarter
30-Sep-2022 [#Q2]
Profit Trend
QoQ- -24.91%
YoY- -161.59%
Quarter Report
VRAX's Result
VRAX's Financial Summary
View:
Show?
Quarter Result
31/03/24 30/09/23 31/03/23 30/09/22 31/03/22 30/09/21 31/03/21 CAGR
Revenue 80 77 3 6 -93 0 110 -10.06%
PBT -3,825 -2,914 -4,004 -1,454 -1,175 -575 -283 138.01%
Tax 0 -5 -4,282 -1,451 17 -589 -249 -
NP -3,824 -2,910 -4,014 -1,444 -1,156 -552 -308 131.37%
Tax Rate - - - - - - - -
Total Cost 3,904 2,986 4,017 1,449 1,064 552 417 110.61%
Ratio Analysis
31/03/24 30/09/23 31/03/23 30/09/22 31/03/22 30/09/21 31/03/21 CAGR
NP Margin -4,784.70 -3,803.47 -143,301.79 -25,062.69 1,245.26 0.00 -280.03 157.34%
Per Share
31/03/24 30/09/23 31/03/23 30/09/22 31/03/22 30/09/21 31/03/21 CAGR
EPS -1.71 -1.64 -2.58 -1.24 -1.02 -0.49 -0.27 84.91%
EPS Diluted -1.71 -1.64 -2.58 -1.24 -1.02 -0.49 -0.27 84.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.